orphan reach™– the first Contract Research Organisation (CRO) purely dedicated to rare diseases.
We are here to accelerate the clinical development of orphan drugs and facilitate patient access to urgently needed new treatments for rare conditions.
For our customers – innovative biotech companies – we provide global CRO services with particular attention to patient recruitment and retention enhanced by home nursing and patient travel support.
Our infrastructure allows access to patients with rare diseases in more than 100 countries world-wide. Our centrally based Project Management teams in Europe, USA and Asia co-ordinate our taskforce in each of the local territories and contribute their orphan expertise to accelerate access to new drugs in a wide range of therapeutic areas.